Vascular Smooth Muscle Cell Calcification Is Mediated by Regulated Exosome Secretion
Matrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor of calcification, is specifically loaded into MVs. However, the processes of fetuin-A intracellular trafficking and MV biogenesis are poorly u...
Saved in:
| Published in | Circulation research Vol. 116; no. 8; pp. 1312 - 1323 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
10.04.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0009-7330 1524-4571 1524-4571 |
| DOI | 10.1161/CIRCRESAHA.116.305012 |
Cover
| Abstract | Matrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor of calcification, is specifically loaded into MVs. However, the processes of fetuin-A intracellular trafficking and MV biogenesis are poorly understood.
The objective of this study is to investigate the regulation, and role, of MV biogenesis in VSMC calcification.
Alexa488-labeled fetuin-A was internalized by human VSMCs, trafficked via the endosomal system, and exocytosed from multivesicular bodies via exosome release. VSMC-derived exosomes were enriched with the tetraspanins CD9, CD63, and CD81, and their release was regulated by sphingomyelin phosphodiesterase 3. Comparative proteomics showed that VSMC-derived exosomes were compositionally similar to exosomes from other cell sources but also shared components with osteoblast-derived MVs including calcium-binding and extracellular matrix proteins. Elevated extracellular calcium was found to induce sphingomyelin phosphodiesterase 3 expression and the secretion of calcifying exosomes from VSMCs in vitro, and chemical inhibition of sphingomyelin phosphodiesterase 3 prevented VSMC calcification. In vivo, multivesicular bodies containing exosomes were observed in vessels from chronic kidney disease patients on dialysis, and CD63 was found to colocalize with calcification. Importantly, factors such as tumor necrosis factor-α and platelet derived growth factor-BB were also found to increase exosome production, leading to increased calcification of VSMCs in response to calcifying conditions.
This study identifies MVs as exosomes and shows that factors that can increase exosome release can promote vascular calcification in response to environmental calcium stress. Modulation of the exosome release pathway may be as a novel therapeutic target for prevention. |
|---|---|
| AbstractList | Matrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor of calcification, is specifically loaded into MVs. However, the processes of fetuin-A intracellular trafficking and MV biogenesis are poorly understood.
The objective of this study is to investigate the regulation, and role, of MV biogenesis in VSMC calcification.
Alexa488-labeled fetuin-A was internalized by human VSMCs, trafficked via the endosomal system, and exocytosed from multivesicular bodies via exosome release. VSMC-derived exosomes were enriched with the tetraspanins CD9, CD63, and CD81, and their release was regulated by sphingomyelin phosphodiesterase 3. Comparative proteomics showed that VSMC-derived exosomes were compositionally similar to exosomes from other cell sources but also shared components with osteoblast-derived MVs including calcium-binding and extracellular matrix proteins. Elevated extracellular calcium was found to induce sphingomyelin phosphodiesterase 3 expression and the secretion of calcifying exosomes from VSMCs in vitro, and chemical inhibition of sphingomyelin phosphodiesterase 3 prevented VSMC calcification. In vivo, multivesicular bodies containing exosomes were observed in vessels from chronic kidney disease patients on dialysis, and CD63 was found to colocalize with calcification. Importantly, factors such as tumor necrosis factor-α and platelet derived growth factor-BB were also found to increase exosome production, leading to increased calcification of VSMCs in response to calcifying conditions.
This study identifies MVs as exosomes and shows that factors that can increase exosome release can promote vascular calcification in response to environmental calcium stress. Modulation of the exosome release pathway may be as a novel therapeutic target for prevention. Matrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor of calcification, is specifically loaded into MVs. However, the processes of fetuin-A intracellular trafficking and MV biogenesis are poorly understood.RATIONALEMatrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor of calcification, is specifically loaded into MVs. However, the processes of fetuin-A intracellular trafficking and MV biogenesis are poorly understood.The objective of this study is to investigate the regulation, and role, of MV biogenesis in VSMC calcification.OBJECTIVEThe objective of this study is to investigate the regulation, and role, of MV biogenesis in VSMC calcification.Alexa488-labeled fetuin-A was internalized by human VSMCs, trafficked via the endosomal system, and exocytosed from multivesicular bodies via exosome release. VSMC-derived exosomes were enriched with the tetraspanins CD9, CD63, and CD81, and their release was regulated by sphingomyelin phosphodiesterase 3. Comparative proteomics showed that VSMC-derived exosomes were compositionally similar to exosomes from other cell sources but also shared components with osteoblast-derived MVs including calcium-binding and extracellular matrix proteins. Elevated extracellular calcium was found to induce sphingomyelin phosphodiesterase 3 expression and the secretion of calcifying exosomes from VSMCs in vitro, and chemical inhibition of sphingomyelin phosphodiesterase 3 prevented VSMC calcification. In vivo, multivesicular bodies containing exosomes were observed in vessels from chronic kidney disease patients on dialysis, and CD63 was found to colocalize with calcification. Importantly, factors such as tumor necrosis factor-α and platelet derived growth factor-BB were also found to increase exosome production, leading to increased calcification of VSMCs in response to calcifying conditions.METHODS AND RESULTSAlexa488-labeled fetuin-A was internalized by human VSMCs, trafficked via the endosomal system, and exocytosed from multivesicular bodies via exosome release. VSMC-derived exosomes were enriched with the tetraspanins CD9, CD63, and CD81, and their release was regulated by sphingomyelin phosphodiesterase 3. Comparative proteomics showed that VSMC-derived exosomes were compositionally similar to exosomes from other cell sources but also shared components with osteoblast-derived MVs including calcium-binding and extracellular matrix proteins. Elevated extracellular calcium was found to induce sphingomyelin phosphodiesterase 3 expression and the secretion of calcifying exosomes from VSMCs in vitro, and chemical inhibition of sphingomyelin phosphodiesterase 3 prevented VSMC calcification. In vivo, multivesicular bodies containing exosomes were observed in vessels from chronic kidney disease patients on dialysis, and CD63 was found to colocalize with calcification. Importantly, factors such as tumor necrosis factor-α and platelet derived growth factor-BB were also found to increase exosome production, leading to increased calcification of VSMCs in response to calcifying conditions.This study identifies MVs as exosomes and shows that factors that can increase exosome release can promote vascular calcification in response to environmental calcium stress. Modulation of the exosome release pathway may be as a novel therapeutic target for prevention.CONCLUSIONSThis study identifies MVs as exosomes and shows that factors that can increase exosome release can promote vascular calcification in response to environmental calcium stress. Modulation of the exosome release pathway may be as a novel therapeutic target for prevention. |
| Author | De Rosales, Rafael Torres Martin Alvarez-Hernandez, Daniel Skepper, Jeremy N. Sanchis, Pilar Muller, Karin Zheng, Ying Furmanik, Malgorzata Reutelingsperger, Chris P. Soong, Daniel Yin, Xiaoke Drozdov, Ignat Mayr, Manuel Davidson, Sean M. Chatrou, Martijn L.L. Shroff, Rukshana Shanahan, Catherine M. Kapustin, Alexander N. Schurgers, Leon J. Bertazzo, Sergio Chester, Adrian |
| Author_xml | – sequence: 1 givenname: Alexander N. surname: Kapustin fullname: Kapustin, Alexander N. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 2 givenname: Martijn L.L. surname: Chatrou fullname: Chatrou, Martijn L.L. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 3 givenname: Ignat surname: Drozdov fullname: Drozdov, Ignat organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 4 givenname: Ying surname: Zheng fullname: Zheng, Ying organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 5 givenname: Sean M. surname: Davidson fullname: Davidson, Sean M. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 6 givenname: Daniel surname: Soong fullname: Soong, Daniel organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 7 givenname: Malgorzata surname: Furmanik fullname: Furmanik, Malgorzata organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 8 givenname: Pilar surname: Sanchis fullname: Sanchis, Pilar organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 9 givenname: Rafael Torres Martin surname: De Rosales fullname: De Rosales, Rafael Torres Martin organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 10 givenname: Daniel surname: Alvarez-Hernandez fullname: Alvarez-Hernandez, Daniel organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 11 givenname: Rukshana surname: Shroff fullname: Shroff, Rukshana organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 12 givenname: Xiaoke surname: Yin fullname: Yin, Xiaoke organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 13 givenname: Karin surname: Muller fullname: Muller, Karin organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 14 givenname: Jeremy N. surname: Skepper fullname: Skepper, Jeremy N. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 15 givenname: Manuel surname: Mayr fullname: Mayr, Manuel organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 16 givenname: Chris P. surname: Reutelingsperger fullname: Reutelingsperger, Chris P. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 17 givenname: Adrian surname: Chester fullname: Chester, Adrian organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 18 givenname: Sergio surname: Bertazzo fullname: Bertazzo, Sergio organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 19 givenname: Leon J. surname: Schurgers fullname: Schurgers, Leon J. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging – sequence: 20 givenname: Catherine M. surname: Shanahan fullname: Shanahan, Catherine M. organization: From the British Heart Foundation Centre of Excellence, Cardiovascular Division, King’s College London, The James Black Centre, London, United Kingdom (A.N.K., I.D., D.S., M.F., P.S., D.A.-H., X.Y., M.M., C.M.S.); Department of Biochemistry—Vascular Aspects, Faculty of Medicine, Health and Life Science, Maastricht University, Maastricht, The Netherlands (M.L.L.C., C.P.R., L.J.S.); Hatter Cardiovascular Institute, University College London, London, United Kingdom (Y.Z., S.M.D.); Department of Imaging |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25711438$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkF1LwzAUhoMo7kN_gpJLbzrz0bQNXo0y3WBD2Ka3JUtPNdIuM2nB_XtbNxW88erkJc97ODwDdLq1W0DoipIRpRG9TWfLdDlZjafjLo84EYSyE9SngoVBKGJ6ivqEEBnEnJMeGnj_RggNOZPnqMfa__ad9NH6WXndlMrhVWVt_YoXjdcl4BTKEqeq1KYwWtXGbvHM4wXkRtWQ480eL-Gl7XVh8mG9rQCvQDvo0At0VqjSw-VxDtHT_WSdToP548MsHc8DzWNRB6C4kBI2PGQ6l1IQLQqhi0QqluS5iIok5iTRNKRUcxUSJkVM8rCIBI1yEgk-RDeHvTtn3xvwdVYZr9vL1RZs4zMaxSyiTEjeotdHtNlUkGc7Zyrl9tm3iRYQB0A7672D4gehJOuMZ7_Gu5wdjLe9uz89beovYbVTpvyn_Qkm3YWg |
| CitedBy_id | crossref_primary_10_1016_j_vph_2016_11_002 crossref_primary_10_1016_j_jcmg_2017_03_005 crossref_primary_10_3389_fphar_2022_857331 crossref_primary_10_5551_jat_RV17045 crossref_primary_10_1038_s41419_018_0315_5 crossref_primary_10_1161_ATVBAHA_117_309513 crossref_primary_10_1016_j_cellsig_2019_109458 crossref_primary_10_1038_s41419_024_06659_w crossref_primary_10_1038_s41401_023_01123_5 crossref_primary_10_1093_ndt_gfz190 crossref_primary_10_1096_fj_202100385R crossref_primary_10_3390_ma12193126 crossref_primary_10_1007_s00424_020_02405_1 crossref_primary_10_3390_ijms25063136 crossref_primary_10_14336_AD_2019_0402 crossref_primary_10_4330_wjc_v12_i7_303 crossref_primary_10_1016_j_ejphar_2018_01_034 crossref_primary_10_1101_cshperspect_a035303 crossref_primary_10_1186_s12933_022_01544_2 crossref_primary_10_23946_2500_0764_2020_5_1_78_93 crossref_primary_10_3390_biomedicines10102491 crossref_primary_10_1016_j_plabm_2016_04_002 crossref_primary_10_1097_MOL_0000000000000214 crossref_primary_10_3389_fendo_2019_00622 crossref_primary_10_1016_j_atherosclerosis_2017_03_005 crossref_primary_10_1016_j_metabol_2023_155767 crossref_primary_10_1016_j_bbalip_2019_158532 crossref_primary_10_3389_fphys_2020_00056 crossref_primary_10_1186_s43556_023_00146_y crossref_primary_10_1039_C6RA27931G crossref_primary_10_3389_fphys_2022_1037230 crossref_primary_10_1111_jcmm_16572 crossref_primary_10_1152_physiol_00037_2018 crossref_primary_10_3389_fendo_2023_1176430 crossref_primary_10_1161_JAHA_118_010805 crossref_primary_10_1161_ATVBAHA_120_313131 crossref_primary_10_1161_CIRCRESAHA_115_306341 crossref_primary_10_1016_j_atherosclerosis_2024_117502 crossref_primary_10_1038_s41598_017_05474_y crossref_primary_10_14814_phy2_12626 crossref_primary_10_3390_biom14010042 crossref_primary_10_1161_ATVBAHA_118_311576 crossref_primary_10_3389_fcvm_2021_630471 crossref_primary_10_1161_CIRCRESAHA_116_307971 crossref_primary_10_3390_cells9030639 crossref_primary_10_1002_jcp_31454 crossref_primary_10_1016_j_ijcard_2018_04_028 crossref_primary_10_1152_physrev_00003_2017 crossref_primary_10_1186_s13287_022_02721_6 crossref_primary_10_3389_fcell_2022_825622 crossref_primary_10_1161_ATVBAHA_115_306349 crossref_primary_10_3390_ijms22094620 crossref_primary_10_3390_ijms22147492 crossref_primary_10_1007_s00109_020_02016_4 crossref_primary_10_1093_cvr_cvab301 crossref_primary_10_1152_physrev_00020_2015 crossref_primary_10_1089_scd_2020_0155 crossref_primary_10_3389_fcell_2022_813885 crossref_primary_10_1186_s12951_023_02176_8 crossref_primary_10_1089_ars_2020_8107 crossref_primary_10_1093_jpp_rgae120 crossref_primary_10_1111_imr_13134 crossref_primary_10_1186_s13287_019_1297_7 crossref_primary_10_1177_03009858221098430 crossref_primary_10_1002_jex2_34 crossref_primary_10_18632_aging_101191 crossref_primary_10_1016_j_matbio_2016_02_003 crossref_primary_10_1172_JCI80851 crossref_primary_10_1093_ndt_gfaa222 crossref_primary_10_3892_etm_2019_7626 crossref_primary_10_3390_molecules26123557 crossref_primary_10_3389_fphys_2018_01394 crossref_primary_10_1134_S0006297923040028 crossref_primary_10_18632_aging_102046 crossref_primary_10_1016_j_bcp_2016_01_015 crossref_primary_10_3389_fimmu_2020_606045 crossref_primary_10_1016_j_atherosclerosis_2016_06_032 crossref_primary_10_1016_j_atherosclerosis_2023_117340 crossref_primary_10_1007_s11560_017_0147_9 crossref_primary_10_1111_joim_13012 crossref_primary_10_1038_s41598_020_58568_5 crossref_primary_10_2478_jim_2021_0007 crossref_primary_10_1038_s41419_022_05064_5 crossref_primary_10_1080_20013078_2017_1322454 crossref_primary_10_1039_C5TB00893J crossref_primary_10_12677_acm_2024_1441249 crossref_primary_10_1038_ncomms13464 crossref_primary_10_1016_j_bbrc_2019_11_005 crossref_primary_10_1161_CIRCRESAHA_115_306324 crossref_primary_10_3389_fcvm_2021_639740 crossref_primary_10_1016_j_smaim_2023_04_002 crossref_primary_10_1038_s41420_021_00720_9 crossref_primary_10_1055_a_2495_1444 crossref_primary_10_1161_ATVBAHA_122_317759 crossref_primary_10_1007_s11033_021_06733_y crossref_primary_10_1016_j_bioactmat_2021_06_004 crossref_primary_10_1016_j_nefroe_2017_03_004 crossref_primary_10_1371_journal_pone_0142335 crossref_primary_10_3390_cells10061276 crossref_primary_10_1093_cvr_cvab046 crossref_primary_10_1016_j_ijcard_2019_09_068 crossref_primary_10_1080_03008207_2018_1444759 crossref_primary_10_3390_pharmaceutics13081138 crossref_primary_10_1016_j_bioactmat_2021_06_005 crossref_primary_10_1016_j_bone_2016_04_007 crossref_primary_10_1080_0886022X_2023_2228920 crossref_primary_10_3389_fonc_2022_869929 crossref_primary_10_1055_s_0044_1789023 crossref_primary_10_1097_BOR_0000000000000244 crossref_primary_10_1186_s13287_024_03970_3 crossref_primary_10_3389_fcell_2021_634853 crossref_primary_10_3390_cells10010131 crossref_primary_10_3389_fcell_2021_651996 crossref_primary_10_3389_fdmed_2022_883336 crossref_primary_10_1016_j_atherosclerosis_2020_02_016 crossref_primary_10_1159_000484925 crossref_primary_10_2174_1381612828666220429081555 crossref_primary_10_3390_biology13080565 crossref_primary_10_1016_j_bbagen_2017_11_005 crossref_primary_10_1016_j_jacbts_2020_02_002 crossref_primary_10_1007_s00223_016_0176_9 crossref_primary_10_1161_ATVBAHA_117_309566 crossref_primary_10_3390_biology13120965 crossref_primary_10_3390_ijms25010388 crossref_primary_10_1016_j_nefro_2016_04_006 crossref_primary_10_3389_fcell_2022_1000760 crossref_primary_10_3390_ijms22147284 crossref_primary_10_1016_j_jbc_2021_100483 crossref_primary_10_1038_nrcardio_2017_7 crossref_primary_10_1093_cvr_cvab038 crossref_primary_10_1161_CIRCRESAHA_117_309419 crossref_primary_10_1152_ajprenal_00017_2015 crossref_primary_10_1161_ATVBAHA_118_314087 crossref_primary_10_1097_MNH_0000000000000712 crossref_primary_10_3389_fphar_2023_1081015 crossref_primary_10_1186_s13104_018_3582_4 crossref_primary_10_1089_dna_2016_3496 crossref_primary_10_1097_HJH_0000000000001202 crossref_primary_10_1177_17085381211032756 crossref_primary_10_1016_j_matbio_2024_09_003 crossref_primary_10_1093_cvr_cvx211 crossref_primary_10_1161_HYPERTENSIONAHA_121_17957 crossref_primary_10_1016_j_cca_2020_10_021 crossref_primary_10_1016_j_jacc_2017_11_013 crossref_primary_10_1161_ATVBAHA_116_308886 crossref_primary_10_1161_CIR_0000000000001254 crossref_primary_10_1016_j_cca_2020_10_022 crossref_primary_10_1093_cvr_cvac031 crossref_primary_10_17802_2306_1278_2021_10_3_26_33 crossref_primary_10_1016_j_semcdb_2015_09_004 crossref_primary_10_1161_CIRCULATIONAHA_122_063402 crossref_primary_10_3390_ijms23169178 crossref_primary_10_1155_2022_9774570 crossref_primary_10_1016_j_atherosclerosis_2021_07_002 crossref_primary_10_1016_j_phrs_2024_107309 crossref_primary_10_1161_ATVBAHA_117_310578 crossref_primary_10_1152_ajpheart_00659_2021 crossref_primary_10_3390_biomedicines11082095 crossref_primary_10_1016_j_jvssci_2020_01_001 crossref_primary_10_1002_jbmr_3073 crossref_primary_10_1038_s41598_018_23353_y crossref_primary_10_1177_09603271211001122 crossref_primary_10_1038_s41569_019_0227_9 crossref_primary_10_1161_ATVBAHA_120_315206 crossref_primary_10_1161_ATVBAHA_115_307009 crossref_primary_10_3389_fcvm_2017_00088 crossref_primary_10_1016_j_celrep_2019_05_038 crossref_primary_10_1139_cjpp_2020_0581 crossref_primary_10_3389_fcvm_2022_854726 crossref_primary_10_3892_ijmm_2022_5195 crossref_primary_10_1172_jci_insight_174977 crossref_primary_10_1016_j_cellsig_2024_111057 crossref_primary_10_1161_ATVBAHA_119_312787 crossref_primary_10_3389_fphar_2022_1004525 crossref_primary_10_1136_jim_2020_001478 crossref_primary_10_3390_ijms19072003 crossref_primary_10_1113_JP272112 crossref_primary_10_1161_ATVBAHA_120_315697 crossref_primary_10_1016_j_biocel_2019_105645 crossref_primary_10_1016_j_bcp_2022_115108 crossref_primary_10_1016_j_gendis_2022_07_023 crossref_primary_10_1016_j_jsb_2020_107577 crossref_primary_10_1159_000453544 crossref_primary_10_3389_fcvm_2018_00187 crossref_primary_10_4155_tde_2018_0051 crossref_primary_10_1016_j_atherosclerosis_2016_05_044 crossref_primary_10_1002_pmic_202300184 crossref_primary_10_1016_j_vph_2016_05_014 crossref_primary_10_1016_j_cellsig_2020_109751 crossref_primary_10_3389_fcvm_2017_00078 crossref_primary_10_1161_CIRCRESAHA_116_310060 crossref_primary_10_1111_jcmm_12923 crossref_primary_10_3390_ijms24032027 crossref_primary_10_3892_ijmm_2018_3699 crossref_primary_10_1042_CS20160378 crossref_primary_10_1093_cvr_cvab244 crossref_primary_10_3390_ijms20163924 crossref_primary_10_3389_fendo_2022_983723 crossref_primary_10_3389_fcvm_2021_687645 crossref_primary_10_1007_s00109_021_02037_7 crossref_primary_10_1093_ajh_hpy083 crossref_primary_10_1111_jcmm_13692 crossref_primary_10_3389_fcvm_2018_00172 crossref_primary_10_1016_j_jss_2020_05_070 crossref_primary_10_3389_fphys_2023_1120308 crossref_primary_10_1002_adfm_202000015 crossref_primary_10_1016_j_joca_2022_11_007 crossref_primary_10_1007_s11560_020_00429_3 crossref_primary_10_1007_s00109_019_01824_7 crossref_primary_10_3390_biology11030414 crossref_primary_10_3389_fimmu_2021_671485 crossref_primary_10_12997_jla_2024_13_3_232 crossref_primary_10_1152_ajpheart_00280_2022 crossref_primary_10_3389_fcvm_2021_734175 crossref_primary_10_1002_JLB_3MIR0221_099R crossref_primary_10_1016_j_exer_2016_08_022 crossref_primary_10_1002_prca_201700097 crossref_primary_10_1016_j_atherosclerosis_2022_01_015 crossref_primary_10_1016_j_athoracsur_2016_07_018 crossref_primary_10_1038_s41598_020_58384_x crossref_primary_10_3390_metabo12040327 crossref_primary_10_3390_ijms252212406 crossref_primary_10_3390_diagnostics10100843 crossref_primary_10_3390_ijms20133272 crossref_primary_10_1038_s41598_021_98177_4 crossref_primary_10_1111_jth_15289 crossref_primary_10_3390_polym14040697 crossref_primary_10_1093_eurheartj_ehw071 crossref_primary_10_3390_biomedicines9040404 crossref_primary_10_1177_15353702221095456 crossref_primary_10_1021_acsomega_3c10427 crossref_primary_10_3390_ijms22073292 crossref_primary_10_1097_MNH_0000000000000509 crossref_primary_10_1161_ATVBAHA_120_314704 crossref_primary_10_1371_journal_pone_0158789 crossref_primary_10_3389_fcell_2020_00227 crossref_primary_10_1160_TH14_11_0962 crossref_primary_10_3390_biom14111465 crossref_primary_10_3390_ijms21072466 crossref_primary_10_1016_j_cca_2019_04_051 crossref_primary_10_1111_jcmm_14761 crossref_primary_10_1007_s10557_016_6698_6 crossref_primary_10_1113_JP271339 crossref_primary_10_1113_JP271338 crossref_primary_10_1002_smll_202402141 crossref_primary_10_1016_j_kint_2017_06_019 crossref_primary_10_3389_fmed_2021_790513 crossref_primary_10_3233_JAD_210101 crossref_primary_10_1016_j_biomaterials_2024_122544 crossref_primary_10_3389_fcvm_2018_00036 crossref_primary_10_3390_biom14121630 crossref_primary_10_1093_ckj_sfaa135 crossref_primary_10_1097_MNH_0000000000000507 crossref_primary_10_1016_j_isci_2019_03_030 crossref_primary_10_14336_AD_2024_0289 crossref_primary_10_3389_fcvm_2021_733985 crossref_primary_10_1371_journal_pone_0191976 crossref_primary_10_1113_JP271340 crossref_primary_10_1186_s12951_024_02779_9 crossref_primary_10_1080_01913123_2016_1272670 crossref_primary_10_3389_fcvm_2019_00006 crossref_primary_10_3390_biomedicines9081061 crossref_primary_10_3390_cells8121509 crossref_primary_10_3390_ijms23063346 crossref_primary_10_1016_j_freeradbiomed_2017_03_026 crossref_primary_10_1042_CS20190680 crossref_primary_10_1111_bph_15163 crossref_primary_10_1161_ATVBAHA_116_306258 crossref_primary_10_1016_j_coph_2016_02_002 crossref_primary_10_1007_s11883_020_00841_z crossref_primary_10_1194_jlr_M079731 crossref_primary_10_1096_fj_201901548R crossref_primary_10_3390_ijms21051713 crossref_primary_10_3390_cells11203279 crossref_primary_10_1093_cvr_cvw206 crossref_primary_10_1111_bph_14868 crossref_primary_10_3390_ijms22179110 crossref_primary_10_1016_j_bbrc_2022_09_076 crossref_primary_10_1016_j_lfs_2020_117837 crossref_primary_10_1016_j_reth_2022_12_007 crossref_primary_10_1155_2020_5169069 crossref_primary_10_3390_nu14132589 crossref_primary_10_1016_j_atherosclerosis_2019_08_016 crossref_primary_10_1016_j_molmed_2017_05_003 crossref_primary_10_1161_CIRCRESAHA_116_308583 crossref_primary_10_3390_cells9071601 crossref_primary_10_1007_s00259_018_4176_z crossref_primary_10_4103_0366_6999_232801 crossref_primary_10_31857_S0320972523040024 crossref_primary_10_3389_fcvm_2022_912358 crossref_primary_10_18632_oncotarget_14878 crossref_primary_10_1007_s11010_021_04328_6 crossref_primary_10_1053_j_ackd_2019_08_014 crossref_primary_10_3390_ijms22179263 crossref_primary_10_1016_j_biopha_2020_111192 crossref_primary_10_3390_ijms21082685 crossref_primary_10_7554_eLife_48191 crossref_primary_10_1089_hum_2019_245 crossref_primary_10_1161_ATVBAHA_120_315506 crossref_primary_10_1186_s12872_024_03758_6 crossref_primary_10_1002_jcp_31021 crossref_primary_10_1161_ATVBAHA_116_306717 crossref_primary_10_1007_s00109_019_01767_z crossref_primary_10_1038_s41598_019_54306_8 crossref_primary_10_1152_ajpheart_00058_2021 crossref_primary_10_1016_j_bioactmat_2023_04_001 crossref_primary_10_1161_CIRCRESAHA_119_316141 crossref_primary_10_3389_fcvm_2022_959457 crossref_primary_10_1126_sciadv_abn1556 crossref_primary_10_1161_ATVBAHA_124_321467 crossref_primary_10_1038_s41413_023_00290_9 crossref_primary_10_1016_j_biopha_2019_108951 crossref_primary_10_1016_j_ajpath_2022_12_007 crossref_primary_10_1016_j_gendis_2017_12_001 crossref_primary_10_1093_femsle_fnx087 crossref_primary_10_1111_acel_12674 crossref_primary_10_1371_journal_pone_0177829 crossref_primary_10_1016_j_kint_2017_07_019 crossref_primary_10_1186_s12967_017_1190_z crossref_primary_10_1371_journal_pone_0156686 crossref_primary_10_1016_j_nefroe_2023_05_014 crossref_primary_10_1016_j_stem_2018_05_009 crossref_primary_10_1016_j_ijcha_2024_101469 crossref_primary_10_1016_j_job_2020_05_006 crossref_primary_10_3390_ijms22020913 crossref_primary_10_3390_toxins11090529 crossref_primary_10_1002_jbm_a_36518 crossref_primary_10_1038_s41401_021_00846_7 crossref_primary_10_1016_j_kint_2018_05_015 crossref_primary_10_1016_S1773_035X_18_30149_7 crossref_primary_10_1042_EBC20170081 crossref_primary_10_1038_s41419_022_04923_5 crossref_primary_10_1248_bpb_b18_00133 crossref_primary_10_1016_j_biomaterials_2019_119407 crossref_primary_10_3389_fmed_2022_997554 crossref_primary_10_3389_fcell_2021_633465 crossref_primary_10_3389_fcvm_2018_00113 crossref_primary_10_1126_sciadv_abb1244 crossref_primary_10_1016_j_cca_2019_09_002 crossref_primary_10_1016_j_cca_2019_11_019 crossref_primary_10_1016_j_nefro_2022_03_002 crossref_primary_10_1136_heartjnl_2016_309667 crossref_primary_10_1007_s40119_017_0091_9 crossref_primary_10_1007_s10856_021_06504_y crossref_primary_10_1161_ATVBAHA_115_302072 crossref_primary_10_1038_s41392_022_00955_7 crossref_primary_10_1097_HJH_0000000000003211 crossref_primary_10_1111_bjh_14104 crossref_primary_10_3390_cryst15010006 crossref_primary_10_1097_FJC_0000000000001357 crossref_primary_10_1161_CIRCRESAHA_119_316159 crossref_primary_10_3390_biomedicines9070804 crossref_primary_10_3389_fcvm_2021_738031 crossref_primary_10_1111_acel_13746 crossref_primary_10_1002_jcp_25935 crossref_primary_10_1161_ATVBAHA_117_309182 crossref_primary_10_3389_fcvm_2021_767488 crossref_primary_10_1002_jrs_5760 crossref_primary_10_1208_s12248_021_00621_w crossref_primary_10_3390_nu15133069 crossref_primary_10_1016_j_yjmcc_2017_12_007 crossref_primary_10_1038_s41467_019_14091_4 crossref_primary_10_1161_ATVBAHA_123_319198 crossref_primary_10_1016_j_kint_2017_08_036 crossref_primary_10_1016_j_pharmthera_2020_107675 crossref_primary_10_1093_ckj_sfac224 crossref_primary_10_3390_cells7080110 crossref_primary_10_3390_ijms20225694 crossref_primary_10_1161_ATVBAHA_120_313792 |
| Cites_doi | 10.1038/ncb2000 10.1016/S0021-9258(18)48095-7 10.1128/MCB.25.18.8299-8310.2005 10.1038/sj.ki.5001874 10.1161/CIRCGENETICS.108.842849 10.1074/jbc.273.32.20121 10.1002/jcp.20826 10.1097/00005344-199406242-00012 10.1681/ASN.2009060640 10.1126/science.1153124 10.1083/jcb.201211138 10.1007/s00223-012-9613-6 10.1002/jcb.22108 10.1039/c3mb70544g 10.1016/j.jacc.2006.10.053 10.1161/CIRCRESAHA.113.301036 10.1016/S0022-1759(00)00321-5 10.1161/CIRCRESAHA.111.261479 10.1038/262226a0 10.1083/jcb.147.3.599 10.1097/01.ASN.0000141960.01035.28 10.1038/35070009 10.1083/jcb.201102051 10.1074/jbc.M210868200 10.1172/JCI9799 10.1161/01.CIR.102.21.2636 10.1161/CIRCRESAHA.110.238808 10.1161/CIRCULATIONAHA.108.783738 10.1038/ng1603 10.1074/jbc.M110.128926 10.1016/j.ajpath.2010.10.006 10.1161/01.ATV.0000059406.92165.31 10.1681/ASN.2004100895 10.1002/pmic.200900351 10.1038/nmat3627 10.1242/jcs.110.16.1867 10.1093/ndt/gfn226 10.3181/00379727-172-41542 10.1016/j.bpj.2010.10.030 10.1074/jbc.M706523200 10.1681/ASN.2009080829 10.1161/CIRCRESAHA.110.234914 10.1083/jcb.101.3.942 |
| ContentType | Journal Article |
| Copyright | 2015 American Heart Association, Inc. |
| Copyright_xml | – notice: 2015 American Heart Association, Inc. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1161/CIRCRESAHA.116.305012 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1524-4571 |
| EndPage | 1323 |
| ExternalDocumentID | 25711438 10_1161_CIRCRESAHA_116_305012 |
| Genre | Video-Audio Media Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: British Heart Foundation grantid: RG/11/14/29056 – fundername: British Heart Foundation grantid: FS/13/2/29892 – fundername: British Heart Foundation grantid: RG/09/008/27923 |
| GroupedDBID | --- -~X .-D .3C .Z2 01R 0R~ 18M 1J1 29B 2WC 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYXX ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACNWC ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADGHP ADHPY AE3 AE6 AEETU AENEX AFBFQ AFDTB AFUWQ AGINI AHMBA AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK C45 CITATION CS3 DIK DIWNM DU5 E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB2 OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W3M W8F WH7 WOQ WOW X3V X3W YFH YOC ZFV ZZMQN CGR CUY CVF ECM EIF NPM 7X8 ADKSD ADSXY |
| ID | FETCH-LOGICAL-c375t-ea3599eb342cd9950c5f5cf89a28dd56f87308c1411c3a4029570d4f6516d0653 |
| ISSN | 0009-7330 1524-4571 |
| IngestDate | Mon Sep 08 09:08:24 EDT 2025 Mon Jul 21 05:56:59 EDT 2025 Tue Jul 01 04:27:46 EDT 2025 Thu Apr 24 22:57:26 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | exosomes extracellular matrix vascular calcification |
| Language | English |
| License | 2015 American Heart Association, Inc. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c375t-ea3599eb342cd9950c5f5cf89a28dd56f87308c1411c3a4029570d4f6516d0653 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 25711438 |
| PQID | 1672612593 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_1672612593 pubmed_primary_25711438 crossref_primary_10_1161_CIRCRESAHA_116_305012 crossref_citationtrail_10_1161_CIRCRESAHA_116_305012 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04-10 2015-Apr-10 20150410 |
| PublicationDateYYYYMMDD | 2015-04-10 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Circulation research |
| PublicationTitleAlternate | Circ Res |
| PublicationYear | 2015 |
| References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 e_1_3_4_41_2 e_1_3_4_6_2 e_1_3_4_40_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_22_2 e_1_3_4_23_2 e_1_3_4_44_2 e_1_3_4_20_2 e_1_3_4_43_2 e_1_3_4_21_2 e_1_3_4_42_2 e_1_3_4_26_2 e_1_3_4_27_2 e_1_3_4_24_2 e_1_3_4_25_2 e_1_3_4_28_2 e_1_3_4_29_2 e_1_3_4_30_2 e_1_3_4_11_2 e_1_3_4_34_2 e_1_3_4_12_2 e_1_3_4_33_2 e_1_3_4_32_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_15_2 e_1_3_4_38_2 e_1_3_4_16_2 e_1_3_4_37_2 e_1_3_4_13_2 e_1_3_4_36_2 e_1_3_4_14_2 e_1_3_4_35_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_18_2 e_1_3_4_39_2 25858057 - Circ Res. 2015 Apr 10;116(8):1281-3. doi: 10.1161/CIRCRESAHA.115.306324. |
| References_xml | – ident: e_1_3_4_18_2 doi: 10.1038/ncb2000 – ident: e_1_3_4_24_2 doi: 10.1016/S0021-9258(18)48095-7 – ident: e_1_3_4_27_2 doi: 10.1128/MCB.25.18.8299-8310.2005 – ident: e_1_3_4_16_2 doi: 10.1038/sj.ki.5001874 – ident: e_1_3_4_10_2 doi: 10.1161/CIRCGENETICS.108.842849 – ident: e_1_3_4_23_2 doi: 10.1074/jbc.273.32.20121 – ident: e_1_3_4_29_2 doi: 10.1002/jcp.20826 – ident: e_1_3_4_38_2 doi: 10.1097/00005344-199406242-00012 – ident: e_1_3_4_5_2 doi: 10.1681/ASN.2009060640 – ident: e_1_3_4_25_2 doi: 10.1126/science.1153124 – ident: e_1_3_4_44_2 doi: 10.1083/jcb.201211138 – ident: e_1_3_4_30_2 doi: 10.1007/s00223-012-9613-6 – ident: e_1_3_4_31_2 doi: 10.1002/jcb.22108 – ident: e_1_3_4_37_2 doi: 10.1039/c3mb70544g – ident: e_1_3_4_9_2 doi: 10.1016/j.jacc.2006.10.053 – ident: e_1_3_4_11_2 doi: 10.1161/CIRCRESAHA.113.301036 – ident: e_1_3_4_22_2 doi: 10.1016/S0022-1759(00)00321-5 – ident: e_1_3_4_39_2 doi: 10.1161/CIRCRESAHA.111.261479 – ident: e_1_3_4_12_2 doi: 10.1038/262226a0 – ident: e_1_3_4_21_2 doi: 10.1083/jcb.147.3.599 – ident: e_1_3_4_3_2 doi: 10.1097/01.ASN.0000141960.01035.28 – ident: e_1_3_4_26_2 doi: 10.1038/35070009 – ident: e_1_3_4_42_2 doi: 10.1083/jcb.201102051 – ident: e_1_3_4_34_2 doi: 10.1074/jbc.M210868200 – ident: e_1_3_4_40_2 doi: 10.1172/JCI9799 – ident: e_1_3_4_43_2 doi: 10.1161/01.CIR.102.21.2636 – ident: e_1_3_4_7_2 doi: 10.1161/CIRCRESAHA.110.238808 – ident: e_1_3_4_35_2 doi: 10.1161/CIRCULATIONAHA.108.783738 – ident: e_1_3_4_41_2 doi: 10.1038/ng1603 – ident: e_1_3_4_19_2 doi: 10.1074/jbc.M110.128926 – ident: e_1_3_4_32_2 doi: 10.1016/j.ajpath.2010.10.006 – ident: e_1_3_4_6_2 doi: 10.1161/01.ATV.0000059406.92165.31 – ident: e_1_3_4_13_2 doi: 10.1681/ASN.2004100895 – ident: e_1_3_4_33_2 doi: 10.1002/pmic.200900351 – ident: e_1_3_4_36_2 doi: 10.1038/nmat3627 – ident: e_1_3_4_17_2 doi: 10.1242/jcs.110.16.1867 – ident: e_1_3_4_15_2 doi: 10.1093/ndt/gfn226 – ident: e_1_3_4_4_2 doi: 10.3181/00379727-172-41542 – ident: e_1_3_4_14_2 doi: 10.1016/j.bpj.2010.10.030 – ident: e_1_3_4_28_2 doi: 10.1074/jbc.M706523200 – ident: e_1_3_4_8_2 doi: 10.1681/ASN.2009080829 – ident: e_1_3_4_2_2 doi: 10.1161/CIRCRESAHA.110.234914 – ident: e_1_3_4_20_2 doi: 10.1083/jcb.101.3.942 – reference: 25858057 - Circ Res. 2015 Apr 10;116(8):1281-3. doi: 10.1161/CIRCRESAHA.115.306324. |
| SSID | ssj0014329 |
| Score | 2.6217072 |
| Snippet | Matrix vesicles (MVs), secreted by vascular smooth muscle cells (VSMCs), form the first nidus for mineralization and fetuin-A, a potent circulating inhibitor... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 1312 |
| SubjectTerms | Adolescent Adult alpha-2-HS-Glycoprotein - metabolism Calcium - metabolism Case-Control Studies Cells, Cultured Cytokines - metabolism Exocytosis Exosomes - metabolism Exosomes - pathology Female Humans Intercellular Signaling Peptides and Proteins - metabolism Male Middle Aged Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology Protein Transport Proteomics - methods RNA Interference Secretory Vesicles - metabolism Secretory Vesicles - pathology Sphingomyelin Phosphodiesterase - genetics Sphingomyelin Phosphodiesterase - metabolism Tetraspanins - metabolism Time Factors Transfection Vascular Calcification - genetics Vascular Calcification - metabolism Vascular Calcification - pathology Vascular Calcification - physiopathology Young Adult |
| Title | Vascular Smooth Muscle Cell Calcification Is Mediated by Regulated Exosome Secretion |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25711438 https://www.proquest.com/docview/1672612593 |
| Volume | 116 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvaFxXbjISb1VCHdtJ_FiVoRbWSYwODV4ix3FgaEumNplgP4Vfy3HspC2My3iJard22nxfj499bgg9H6ZUZzRVHqxtqcdCTT0ZKO7FgmiqYEOSpeZAf7YfTg7Z6yN-1Ot9X_NaqqvUVxeXxpX8D6rQB7iaKNkrINtNCh3wGvCFKyAM13_C-H3rRvrutIQnPpjVS_jEYGzO48bypHG3swBPl41JRlZW4TywFeihsfu1XJan2py7m3hGB1KbuuB4oVx5r4HLCtSdHr-RZ6YQWLERJTPY99f8BapFWbt4oOr4SzHY8_e6t18uyousPG9E1KdCds43Hz9rK30-tGuqO5Ig3FhXnHNqK2aFF1FncNFOsgbMY9zWW-lEr42zdByL1wQpoc67WrumjUr-VeCHRuCPpwdjIOxoMjI9PsiwYTt8PcH2Twtf547YbIRCkqymMe3ETnMNXQ8i0MuMwf_tykLFaCDaKn3mp7roMJjmxaXfZlPv-c1mplFq5tvoltuN4JGl1m3U08UddGPm_C3uonnLMGwZhi3DsGEY3mAYni5xyzCcfsMdw7BjGO4Ydg8dvtqdjyeeq8PhKRrxytOSciF0SlmgMiH4UPGcqzwWMoizjId5DMtErAgjRFHJhoHg0TBjechJmJncx_fRVlEWegdhpYgOo5xmKZdMZUqksGOPFCixcRwqIfuItU8pUS5JvamVcpL8EaM-8rthZzZLy98GPGshSECeGiOZLHRZLxMSRiarHhe0jx5YbLopYXkjAHz88Kq3e4Rurv4nj9FWtaj1E1Bmq_Rpw6ofFjeYFw |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vascular+Smooth+Muscle+Cell+Calcification+Is+Mediated+by+Regulated+Exosome+Secretion&rft.jtitle=Circulation+research&rft.au=Kapustin%2C+Alexander+N.&rft.au=Chatrou%2C+Martijn+L.L.&rft.au=Drozdov%2C+Ignat&rft.au=Zheng%2C+Ying&rft.date=2015-04-10&rft.issn=0009-7330&rft.eissn=1524-4571&rft.volume=116&rft.issue=8&rft.spage=1312&rft.epage=1323&rft_id=info:doi/10.1161%2FCIRCRESAHA.116.305012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_CIRCRESAHA_116_305012 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon |